Some studies believe that these CD7-loss T cells still perform a certain anti-infection function, but others believe that the cells are functionally deficient, which may cause viral reactivation (such as EBV and cytomegalovirus (CMV)) or other opportunistic infections after CAR-T cell treatment [11, 13]. This evidence concerns the gene CD7 and infection.